Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...

Cyclotek and Telix Pharmaceuticals Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New Zealand MELBOURNE, Australia, July 31, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”) is pleased to announce the completion of a Master Services Agreement (“MSA”) with Cyclotek (Aust) Pty...